Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma von Lowe, Michael C., Olson, Brian, Martinez, Anthony, Hammons, Jacklyn, Delman, Keith A., Yushak, Melinda Lynne, Allor, Melanie, Reilly, Christine A., Mallow, Crystal L., Evans, Elizabeth E., Fisher, Terrence Lee, Lesinski, Gregory B., Kudchadkar, Ragini Reiney

Volltext